The Latest Breaking News from Citi

Rachel Reeves warned up to £25bn of tax rises needed to avoid austerity

Rachel Reeves’ first budget could be ‘the most consequential since at least 2010’, the IFS said

The Independent UK · Oct 10, 2024

Rachel Reeves told she needs £25 billion tax increases to avoid austerity

Rachel Reeves may need to raise up to £25 billion from tax increases if she wants to keep spending rising with national income, the Institute for…

The National (Scotland) · Oct 10, 2024

Who has time for a power lunch? The real business happens at 4 p.m. 'power hour.'

In the post-covid era, the bars of some of Manhattan's most elegant restaurants are packed by 4:30 p.m. Just don't call it "happy hour."

Fortune · Oct 3, 2024

The Wall Street economist who nailed the Fed's 'joyous' rate cut sees the same thing again

"In other contexts, a larger move may convey greater concern about growth, but Powell repeatedly stressed this was basically a joyous cut as ebbing inflation allows the Fed to act to preserve a strong labor market."

Fortune · Sep 21, 2024

1 'Strong Buy' Energy Stock That's a Free Cash Flow Gusher

Seadrill Limited, a leading offshore drilling company, is poised to capitalize on the industry's resurgence, with a strong free cash flow outlook and strategic market advantages that could drive significant upside.

Barchart · Sep 20, 2024

How Surging AI Demand Could Drive This Dividend Stock Higher

Eaton, a diversified power management company, is poised to benefit from the surging demand for AI-driven data centers, with its innovative power solutions and strong dividend growth making it an attractive investment opportunity.

Barchart · Sep 19, 2024

1 Analyst Says This AI Stock Will Overshadow Nvidia

The new product launch bodes well for the future of this AI stock.

Barchart · Sep 18, 2024

Should You Buy This Dividend Stock with Almost 4% Yield That Could Double in Value?

Citigroup stock has a forward dividend yield of 4%. Wells Fargo believes that the stock could double over the next two and a half years as the company's CEO Jane Fraser tries to turn around the lender.

Barchart · Sep 17, 2024

Up 1,123% YTD, Is It Too Late to Buy This Breakout Biotech Stock?

Summit Therapeutics is a clinical-stage biotech company that has returned over 1,100% in 2024. Is the stock still a good buy right now?

Barchart · Sep 16, 2024

2 Top AI Stock Picks That Aren't Nvidia

There is more to AI than just Nvidia, as analysts have named these stocks their new favorites.

Barchart · Sep 16, 2024